192 related articles for article (PubMed ID: 23077247)
21. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.
Dolcetti L; Peranzoni E; Ugel S; Marigo I; Fernandez Gomez A; Mesa C; Geilich M; Winkels G; Traggiai E; Casati A; Grassi F; Bronte V
Eur J Immunol; 2010 Jan; 40(1):22-35. PubMed ID: 19941314
[TBL] [Abstract][Full Text] [Related]
22. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
Greifenberg V; Ribechini E; Rössner S; Lutz MB
Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
[TBL] [Abstract][Full Text] [Related]
23. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.
Chen S; Akbar SM; Abe M; Hiasa Y; Onji M
Clin Exp Immunol; 2011 Oct; 166(1):134-42. PubMed ID: 21762128
[TBL] [Abstract][Full Text] [Related]
25. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
[TBL] [Abstract][Full Text] [Related]
26. Tumor-induced CD11b(+) Gr-1(+) myeloid-derived suppressor cells exacerbate immune-mediated hepatitis in mice in a CD40-dependent manner.
Kapanadze T; Medina-Echeverz J; Gamrekelashvili J; Weiss JM; Wiltrout RH; Kapoor V; Hawk N; Terabe M; Berzofsky JA; Manns MP; Wang E; Marincola FM; Korangy F; Greten TF
Eur J Immunol; 2015 Apr; 45(4):1148-58. PubMed ID: 25616156
[TBL] [Abstract][Full Text] [Related]
27. Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer.
Forghani P; Waller EK
Breast Cancer Res Treat; 2015 Aug; 153(1):21-30. PubMed ID: 26208484
[TBL] [Abstract][Full Text] [Related]
28. Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.
Hong EH; Chang SY; Lee BR; Kim YS; Lee JM; Kang CY; Kweon MN; Ko HJ
Int J Cancer; 2013 Jun; 132(12):2839-48. PubMed ID: 23184679
[TBL] [Abstract][Full Text] [Related]
29. Editorial: "Invisible" MDSC in tumor-bearing individuals after antibody depletion: fact or fiction?
Ma C; Greten TF
J Leukoc Biol; 2016 Jun; 99(6):794. PubMed ID: 27252522
[No Abstract] [Full Text] [Related]
30. Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.
Tong Z; Liu W; Yan H; Dong C
Immunology; 2015 Oct; 146(2):339-46. PubMed ID: 26211676
[TBL] [Abstract][Full Text] [Related]
31. Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).
Nelson N; Szekeres K; Cooper D; Ghansah T
J Vis Exp; 2012 Jun; (64):e3875. PubMed ID: 22733203
[TBL] [Abstract][Full Text] [Related]
32. Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.
Gong W; Ge F; Liu D; Wu Y; Liu F; Kim BS; Huang T; Koulmanda M; Robson SC; Strom TB
Clin Immunol; 2014 Jul; 153(1):8-16. PubMed ID: 24691417
[TBL] [Abstract][Full Text] [Related]
33. Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1- polymorphonuclear leukocyte-like cells.
Brown CR; Blaho VA; Loiacono CM
Infect Immun; 2004 Sep; 72(9):4956-65. PubMed ID: 15321987
[TBL] [Abstract][Full Text] [Related]
34. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
[TBL] [Abstract][Full Text] [Related]
36. Depletion of Gr-1+, but not Ly6G+, immune cells exacerbates virus replication and disease in an intranasal model of herpes simplex virus type 1 infection.
Wojtasiak M; Pickett DL; Tate MD; Londrigan SL; Bedoui S; Brooks AG; Reading PC
J Gen Virol; 2010 Sep; 91(Pt 9):2158-66. PubMed ID: 20538903
[TBL] [Abstract][Full Text] [Related]
37. Functional characterization of myeloid-derived suppressor cell subpopulations during the development of experimental arthritis.
Wang W; Jiao Z; Duan T; Liu M; Zhu B; Zhang Y; Xu Q; Wang R; Xiong Y; Xu H; Lu L
Eur J Immunol; 2015 Feb; 45(2):464-73. PubMed ID: 25352399
[TBL] [Abstract][Full Text] [Related]
38. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatase 1B deficiency ameliorates murine experimental colitis via the expansion of myeloid-derived suppressor cells.
Zhang J; Wang B; Zhang W; Wei Y; Bian Z; Zhang CY; Li L; Zen K
PLoS One; 2013; 8(8):e70828. PubMed ID: 23951017
[TBL] [Abstract][Full Text] [Related]
40. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]